April 28, 2022
JelikaLite was awarded a National Science Foundation grant SBIR Phase 1: “EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism”. This new $256K grant will allow us to continue developing Cognilum, an intelligent non-invasive therapeutic personalized medical device, designed to be easily administered in the child’s home. This data-device modality could be disruptive in the Autism treatment standard of care.
Learn More
